Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Heterogeneous clinicopathological findings and patient-reported outcomes in adults with MN1-altered CNS tumors: A case report and systematic literature review.
Frederico SC, Vera E, Abdullaev Z, Acquaye A, Aldape K, Boris L, Briceno N, Choi A, Christ A, Cooper D, Grajkowska E, Kunst T, Leeper HE, Levine J, Lollo N, Pratt D, Quezado M, Shah R, Wall K, Gilbert MR, Armstrong TS, Penas-Prado M. Frederico SC, et al. Among authors: kunst t. Front Oncol. 2023 Jan 19;13:1099618. doi: 10.3389/fonc.2023.1099618. eCollection 2023. Front Oncol. 2023. PMID: 36741001 Free PMC article.
Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial.
King AL, Roche KN, Leeper HE, Vera E, Mendoza T, Mentges K, Acquaye AA, Adegbesan K, Boris L, Burton E, Choi A, Grajkowska E, Kunst T, Levine J, Lollo N, Miller H, Panzer M, Penas-Prado M, Pillai V, Polskin L, Reyes J, Sahebjam S, Stockdill M, Theeler BJ, Wu J, Gilbert MR, Armstrong TS. King AL, et al. Among authors: kunst t. Res Sq [Preprint]. 2023 Jan 31:rs.3.rs-2522094. doi: 10.21203/rs.3.rs-2522094/v1. Res Sq. 2023. Update in: J Neurooncol. 2023 Mar;162(1):137-145. doi: 10.1007/s11060-023-04271-0 PMID: 36789426 Free PMC article. Updated. Preprint.
Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial.
King AL, Roche KN, Leeper HE, Vera E, Mendoza T, Mentges K, Acquaye-Mallory AA, Adegbesan KA, Boris L, Burton E, Choi A, Grajkowska E, Kunst T, Levine J, Lollo N, Miller H, Panzer M, Penas-Prado M, Pillai V, Polskin L, Reyes J, Sahebjam S, Stockdill ML, Theeler BJ, Wu J, Gilbert MR, Armstrong TS. King AL, et al. Among authors: kunst t. J Neurooncol. 2023 Mar;162(1):137-145. doi: 10.1007/s11060-023-04271-0. Epub 2023 Mar 8. J Neurooncol. 2023. PMID: 36884201 Free PMC article. Clinical Trial.
Long-term survivors of glioblastoma: Tumor molecular, clinical, and imaging findings.
Briceno N, Vera E, Komlodi-Pasztor E, Abdullaev Z, Choi A, Grajkowska E, Kunst T, Levine J, Lindsley M, Fernandez K, Reyes J, Boris L, Burton E, Panzer M, Polskin L, Penas-Prado M, Pillai T, Theeler BJ, Wu J, Wall K, Papanicolau-Sengos A, Quezado M, Smirniotopoulos J, Aldape K, Armstrong TS, Gilbert MR. Briceno N, et al. Among authors: kunst t. Neurooncol Adv. 2024 Feb 8;6(1):vdae019. doi: 10.1093/noajnl/vdae019. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38420614 Free PMC article.
Assessing sleep in primary brain tumor patients using smart wearables and patient-reported data: Feasibility and interim analysis of an observational study.
Pascoe MM, Wollet AR, De La Cruz Minyety J, Vera E, Miller H, Celiku O, Leeper H, Fernandez K, Reyes J, Young D Jr, Acquaye-Mallory A, Adegbesan K, Boris L, Burton E, Chambers CP, Choi A, Grajkowska E, Kunst T, Levine J, Panzer M, Penas-Prado M, Pillai V, Polskin L, Wu J, Gilbert MR, Mendoza T, King AL, Shuboni-Mulligan D, Armstrong TS. Pascoe MM, et al. Among authors: kunst t. Neurooncol Pract. 2024 May 24;11(5):640-651. doi: 10.1093/nop/npae048. eCollection 2024 Oct. Neurooncol Pract. 2024. PMID: 39279778 Free article.
Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas.
Zhang Y, Calado R, Rao M, Hong JA, Meeker AK, Dumitriu B, Atay S, McCormick PJ, Garfield SH, Wangsa D, Padilla-Nash HM, Burkett S, Zhang M, Kunst TF, Peterson NR, Xi S, Inchauste S, Altorki NK, Casson AG, Beer DG, Harris CC, Ried T, Young NS, Schrump DS. Zhang Y, et al. Among authors: kunst tf. PLoS One. 2014 Jul 1;9(7):e101010. doi: 10.1371/journal.pone.0101010. eCollection 2014. PLoS One. 2014. PMID: 24983628 Free PMC article.
17 results